The global Glaucoma Treatment System market size is predicted to grow from US$ 4983 million in 2025 to US$ 6436 million in 2031; it is expected to grow at a CAGR of 4.4% from 2025 to 2031.
Glaucoma treatment drugs and devices are specifically used to treat glaucoma. These devices and drugs aim to treat glaucoma by reducing intraocular pressure, improving blood circulation in the eye, increasing the drainage of aqueous humor, or reducing the production of aqueous humor through different mechanisms and methods.
United States market for Glaucoma Treatment System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Glaucoma Treatment System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Glaucoma Treatment System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Glaucoma Treatment System players cover Allergan, AbbVie, Alcon, Merck & Co. Inc, Pfizer Inc, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The “Glaucoma Treatment System Industry Forecast†looks at past sales and reviews total world Glaucoma Treatment System sales in 2024, providing a comprehensive analysis by region and market sector of projected Glaucoma Treatment System sales for 2025 through 2031. With Glaucoma Treatment System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glaucoma Treatment System industry.
This Insight Report provides a comprehensive analysis of the global Glaucoma Treatment System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glaucoma Treatment System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Glaucoma Treatment System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glaucoma Treatment System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glaucoma Treatment System.
This report presents a comprehensive overview, market shares, and growth opportunities of Glaucoma Treatment System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
‌Audio and Video System Equipment‌
‌Conference Speaking Equipment‌
Conference Recording and Storage Equipment‌
Others
Segmentation by Application:
Education
Government
Manufacturing
Financial services
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Allergan
AbbVie
Alcon
Merck & Co. Inc
Pfizer Inc
Johnson & Johnson Vision
Aerie Pharmaceuticals
Akorn Inc.
Allergan plc
Carl Zeiss Meditec AG
STAAR Surgical Company
Inotek Pharmaceuticals
Santen Pharmaceutical Co. Ltd
Glaukos Corporation
Bausch & Lomb Incorporated
Bausch Health Companies Inc.
Topcon Corporation
Lumenis Ltd.
Iridex Corporation
Ophthalmic Instrument Company
New World Medical, Inc.
Ellex Medical Lasers Limited
NIDEK CO., LTD.
Ziemer Ophthalmic Systems
Reichert Technologies
Key Questions Addressed in this Report
What is the 10-year outlook for the global Glaucoma Treatment System market?
What factors are driving Glaucoma Treatment System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glaucoma Treatment System market opportunities vary by end market size?
How does Glaucoma Treatment System break out by Type, by Application?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Glaucoma Treatment System Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Glaucoma Treatment System by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Glaucoma Treatment System by Country/Region, 2020, 2024 & 2031
2.2 Glaucoma Treatment System Segment by Type
2.2.1 ‌Audio and Video System Equipment‌
2.2.2 ‌Conference Speaking Equipment‌
2.2.3 Conference Recording and Storage Equipment‌
2.2.4 Others
2.3 Glaucoma Treatment System Sales by Type
2.3.1 Global Glaucoma Treatment System Sales Market Share by Type (2020-2025)
2.3.2 Global Glaucoma Treatment System Revenue and Market Share by Type (2020-2025)
2.3.3 Global Glaucoma Treatment System Sale Price by Type (2020-2025)
2.4 Glaucoma Treatment System Segment by Application
2.4.1 Education
2.4.2 Government
2.4.3 Manufacturing
2.4.4 Financial services
2.4.5 Others
2.5 Glaucoma Treatment System Sales by Application
2.5.1 Global Glaucoma Treatment System Sale Market Share by Application (2020-2025)
2.5.2 Global Glaucoma Treatment System Revenue and Market Share by Application (2020-2025)
2.5.3 Global Glaucoma Treatment System Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Glaucoma Treatment System Breakdown Data by Company
3.1.1 Global Glaucoma Treatment System Annual Sales by Company (2020-2025)
3.1.2 Global Glaucoma Treatment System Sales Market Share by Company (2020-2025)
3.2 Global Glaucoma Treatment System Annual Revenue by Company (2020-2025)
3.2.1 Global Glaucoma Treatment System Revenue by Company (2020-2025)
3.2.2 Global Glaucoma Treatment System Revenue Market Share by Company (2020-2025)
3.3 Global Glaucoma Treatment System Sale Price by Company
3.4 Key Manufacturers Glaucoma Treatment System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Glaucoma Treatment System Product Location Distribution
3.4.2 Players Glaucoma Treatment System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Glaucoma Treatment System by Geographic Region
4.1 World Historic Glaucoma Treatment System Market Size by Geographic Region (2020-2025)
4.1.1 Global Glaucoma Treatment System Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Glaucoma Treatment System Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Glaucoma Treatment System Market Size by Country/Region (2020-2025)
4.2.1 Global Glaucoma Treatment System Annual Sales by Country/Region (2020-2025)
4.2.2 Global Glaucoma Treatment System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Glaucoma Treatment System Sales Growth
4.4 APAC Glaucoma Treatment System Sales Growth
4.5 Europe Glaucoma Treatment System Sales Growth
4.6 Middle East & Africa Glaucoma Treatment System Sales Growth
5 Americas
5.1 Americas Glaucoma Treatment System Sales by Country
5.1.1 Americas Glaucoma Treatment System Sales by Country (2020-2025)
5.1.2 Americas Glaucoma Treatment System Revenue by Country (2020-2025)
5.2 Americas Glaucoma Treatment System Sales by Type (2020-2025)
5.3 Americas Glaucoma Treatment System Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glaucoma Treatment System Sales by Region
6.1.1 APAC Glaucoma Treatment System Sales by Region (2020-2025)
6.1.2 APAC Glaucoma Treatment System Revenue by Region (2020-2025)
6.2 APAC Glaucoma Treatment System Sales by Type (2020-2025)
6.3 APAC Glaucoma Treatment System Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Glaucoma Treatment System by Country
7.1.1 Europe Glaucoma Treatment System Sales by Country (2020-2025)
7.1.2 Europe Glaucoma Treatment System Revenue by Country (2020-2025)
7.2 Europe Glaucoma Treatment System Sales by Type (2020-2025)
7.3 Europe Glaucoma Treatment System Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Glaucoma Treatment System by Country
8.1.1 Middle East & Africa Glaucoma Treatment System Sales by Country (2020-2025)
8.1.2 Middle East & Africa Glaucoma Treatment System Revenue by Country (2020-2025)
8.2 Middle East & Africa Glaucoma Treatment System Sales by Type (2020-2025)
8.3 Middle East & Africa Glaucoma Treatment System Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glaucoma Treatment System
10.3 Manufacturing Process Analysis of Glaucoma Treatment System
10.4 Industry Chain Structure of Glaucoma Treatment System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Glaucoma Treatment System Distributors
11.3 Glaucoma Treatment System Customer
12 World Forecast Review for Glaucoma Treatment System by Geographic Region
12.1 Global Glaucoma Treatment System Market Size Forecast by Region
12.1.1 Global Glaucoma Treatment System Forecast by Region (2026-2031)
12.1.2 Global Glaucoma Treatment System Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Glaucoma Treatment System Forecast by Type (2026-2031)
12.7 Global Glaucoma Treatment System Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Allergan
13.1.1 Allergan Company Information
13.1.2 Allergan Glaucoma Treatment System Product Portfolios and Specifications
13.1.3 Allergan Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Allergan Main Business Overview
13.1.5 Allergan Latest Developments
13.2 AbbVie
13.2.1 AbbVie Company Information
13.2.2 AbbVie Glaucoma Treatment System Product Portfolios and Specifications
13.2.3 AbbVie Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 AbbVie Main Business Overview
13.2.5 AbbVie Latest Developments
13.3 Alcon
13.3.1 Alcon Company Information
13.3.2 Alcon Glaucoma Treatment System Product Portfolios and Specifications
13.3.3 Alcon Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Alcon Main Business Overview
13.3.5 Alcon Latest Developments
13.4 Merck & Co. Inc
13.4.1 Merck & Co. Inc Company Information
13.4.2 Merck & Co. Inc Glaucoma Treatment System Product Portfolios and Specifications
13.4.3 Merck & Co. Inc Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck & Co. Inc Main Business Overview
13.4.5 Merck & Co. Inc Latest Developments
13.5 Pfizer Inc
13.5.1 Pfizer Inc Company Information
13.5.2 Pfizer Inc Glaucoma Treatment System Product Portfolios and Specifications
13.5.3 Pfizer Inc Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Pfizer Inc Main Business Overview
13.5.5 Pfizer Inc Latest Developments
13.6 Johnson & Johnson Vision
13.6.1 Johnson & Johnson Vision Company Information
13.6.2 Johnson & Johnson Vision Glaucoma Treatment System Product Portfolios and Specifications
13.6.3 Johnson & Johnson Vision Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Johnson & Johnson Vision Main Business Overview
13.6.5 Johnson & Johnson Vision Latest Developments
13.7 Aerie Pharmaceuticals
13.7.1 Aerie Pharmaceuticals Company Information
13.7.2 Aerie Pharmaceuticals Glaucoma Treatment System Product Portfolios and Specifications
13.7.3 Aerie Pharmaceuticals Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Aerie Pharmaceuticals Main Business Overview
13.7.5 Aerie Pharmaceuticals Latest Developments
13.8 Akorn Inc.
13.8.1 Akorn Inc. Company Information
13.8.2 Akorn Inc. Glaucoma Treatment System Product Portfolios and Specifications
13.8.3 Akorn Inc. Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Akorn Inc. Main Business Overview
13.8.5 Akorn Inc. Latest Developments
13.9 Allergan plc
13.9.1 Allergan plc Company Information
13.9.2 Allergan plc Glaucoma Treatment System Product Portfolios and Specifications
13.9.3 Allergan plc Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Allergan plc Main Business Overview
13.9.5 Allergan plc Latest Developments
13.10 Carl Zeiss Meditec AG
13.10.1 Carl Zeiss Meditec AG Company Information
13.10.2 Carl Zeiss Meditec AG Glaucoma Treatment System Product Portfolios and Specifications
13.10.3 Carl Zeiss Meditec AG Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Carl Zeiss Meditec AG Main Business Overview
13.10.5 Carl Zeiss Meditec AG Latest Developments
13.11 STAAR Surgical Company
13.11.1 STAAR Surgical Company Company Information
13.11.2 STAAR Surgical Company Glaucoma Treatment System Product Portfolios and Specifications
13.11.3 STAAR Surgical Company Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 STAAR Surgical Company Main Business Overview
13.11.5 STAAR Surgical Company Latest Developments
13.12 Inotek Pharmaceuticals
13.12.1 Inotek Pharmaceuticals Company Information
13.12.2 Inotek Pharmaceuticals Glaucoma Treatment System Product Portfolios and Specifications
13.12.3 Inotek Pharmaceuticals Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Inotek Pharmaceuticals Main Business Overview
13.12.5 Inotek Pharmaceuticals Latest Developments
13.13 Santen Pharmaceutical Co. Ltd
13.13.1 Santen Pharmaceutical Co. Ltd Company Information
13.13.2 Santen Pharmaceutical Co. Ltd Glaucoma Treatment System Product Portfolios and Specifications
13.13.3 Santen Pharmaceutical Co. Ltd Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Santen Pharmaceutical Co. Ltd Main Business Overview
13.13.5 Santen Pharmaceutical Co. Ltd Latest Developments
13.14 Glaukos Corporation
13.14.1 Glaukos Corporation Company Information
13.14.2 Glaukos Corporation Glaucoma Treatment System Product Portfolios and Specifications
13.14.3 Glaukos Corporation Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Glaukos Corporation Main Business Overview
13.14.5 Glaukos Corporation Latest Developments
13.15 Bausch & Lomb Incorporated
13.15.1 Bausch & Lomb Incorporated Company Information
13.15.2 Bausch & Lomb Incorporated Glaucoma Treatment System Product Portfolios and Specifications
13.15.3 Bausch & Lomb Incorporated Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Bausch & Lomb Incorporated Main Business Overview
13.15.5 Bausch & Lomb Incorporated Latest Developments
13.16 Bausch Health Companies Inc.
13.16.1 Bausch Health Companies Inc. Company Information
13.16.2 Bausch Health Companies Inc. Glaucoma Treatment System Product Portfolios and Specifications
13.16.3 Bausch Health Companies Inc. Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Bausch Health Companies Inc. Main Business Overview
13.16.5 Bausch Health Companies Inc. Latest Developments
13.17 Topcon Corporation
13.17.1 Topcon Corporation Company Information
13.17.2 Topcon Corporation Glaucoma Treatment System Product Portfolios and Specifications
13.17.3 Topcon Corporation Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Topcon Corporation Main Business Overview
13.17.5 Topcon Corporation Latest Developments
13.18 Lumenis Ltd.
13.18.1 Lumenis Ltd. Company Information
13.18.2 Lumenis Ltd. Glaucoma Treatment System Product Portfolios and Specifications
13.18.3 Lumenis Ltd. Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Lumenis Ltd. Main Business Overview
13.18.5 Lumenis Ltd. Latest Developments
13.19 Iridex Corporation
13.19.1 Iridex Corporation Company Information
13.19.2 Iridex Corporation Glaucoma Treatment System Product Portfolios and Specifications
13.19.3 Iridex Corporation Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.19.4 Iridex Corporation Main Business Overview
13.19.5 Iridex Corporation Latest Developments
13.20 Ophthalmic Instrument Company
13.20.1 Ophthalmic Instrument Company Company Information
13.20.2 Ophthalmic Instrument Company Glaucoma Treatment System Product Portfolios and Specifications
13.20.3 Ophthalmic Instrument Company Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.20.4 Ophthalmic Instrument Company Main Business Overview
13.20.5 Ophthalmic Instrument Company Latest Developments
13.21 New World Medical, Inc.
13.21.1 New World Medical, Inc. Company Information
13.21.2 New World Medical, Inc. Glaucoma Treatment System Product Portfolios and Specifications
13.21.3 New World Medical, Inc. Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.21.4 New World Medical, Inc. Main Business Overview
13.21.5 New World Medical, Inc. Latest Developments
13.22 Ellex Medical Lasers Limited
13.22.1 Ellex Medical Lasers Limited Company Information
13.22.2 Ellex Medical Lasers Limited Glaucoma Treatment System Product Portfolios and Specifications
13.22.3 Ellex Medical Lasers Limited Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.22.4 Ellex Medical Lasers Limited Main Business Overview
13.22.5 Ellex Medical Lasers Limited Latest Developments
13.23 NIDEK CO., LTD.
13.23.1 NIDEK CO., LTD. Company Information
13.23.2 NIDEK CO., LTD. Glaucoma Treatment System Product Portfolios and Specifications
13.23.3 NIDEK CO., LTD. Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.23.4 NIDEK CO., LTD. Main Business Overview
13.23.5 NIDEK CO., LTD. Latest Developments
13.24 Ziemer Ophthalmic Systems
13.24.1 Ziemer Ophthalmic Systems Company Information
13.24.2 Ziemer Ophthalmic Systems Glaucoma Treatment System Product Portfolios and Specifications
13.24.3 Ziemer Ophthalmic Systems Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.24.4 Ziemer Ophthalmic Systems Main Business Overview
13.24.5 Ziemer Ophthalmic Systems Latest Developments
13.25 Reichert Technologies
13.25.1 Reichert Technologies Company Information
13.25.2 Reichert Technologies Glaucoma Treatment System Product Portfolios and Specifications
13.25.3 Reichert Technologies Glaucoma Treatment System Sales, Revenue, Price and Gross Margin (2020-2025)
13.25.4 Reichert Technologies Main Business Overview
13.25.5 Reichert Technologies Latest Developments
14 Research Findings and Conclusion
Ìı
Ìı
*If Applicable.
